Discounted Cash Flow (DCF) Analysis Unlevered

BioVie Inc. (BIVI)

$0.6463

-0.06 (-8.37%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 0.6463 | undervalue

Operating Data

Year
A/P
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Revenue ----------
Revenue (%)
EBITDA ----------
EBITDA (%)
EBIT ----------
EBIT (%)
Depreciation ----------
Depreciation (%)

Balance Sheet Data

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash ----------
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable ----------
Accounts Payable (%)
Capital Expenditure ----------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.6,463
Beta 1.335
Diluted Shares Outstanding 32.48
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 29.82%
Risk-Free Rate
Market Risk Premium
Cost of Equity 10.657
Total Debt 14.42
Total Equity 20.99
Total Capital 35.41
Debt Weighting 40.72
Equity Weighting 59.28
Wacc

Build Up Free Cash

Year
A/P
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Revenue ----------
EBITDA ----------
EBIT ----------
Tax Rate 2.10%-28.62%-0.43%12.60%0.00%-2.87%-2.87%-2.87%-2.87%-2.87%
EBIAT ----------
Depreciation ----------
Accounts Receivable ----------
Inventories ----------
Accounts Payable ----------
Capital Expenditure ----------
UFCF ----------
WACC
PV UFCF ----------
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 18.46
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -5.04
Equity Value -
Shares Outstanding 32.48
Equity Value Per Share -